Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Impact of CYP2C9, VKORC1 and CYP4F2 genetic polymorphisms on maintenance warfarin dosage in Han-Chinese patients: A systematic review and meta-analysis

Published:2016-09 Issue: Volume:9 Page:197-209
ISSN:2214-5400
Container-title:Meta Gene
language:en
Short-container-title:Meta Gene

Author:

Zhang Jinhua,Chen Zhijie,Chen Chunmei

Funder

Scientific Research Foundation

Publisher

Elsevier BV

Subject

Genetics(clinical),Genetics

Reference74 articles.

1. Effect of NQO1 and CYP4F2 genotypes on warfarin dose requirements in Hispanic-Americans and African-Americans;Bress;Pharmacogenomics,2012

2. Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective study;Carlquist;J. Thromb. Thrombolysis,2006

3. Genetic and clinical predictors of warfarin dose requirements in African Americans;Cavallari;Clin. Pharmacol. Ther.,2010

4. CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement;Cen;British Journal Of Clinical Pharmacology,2010

5. Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese;Cha;Hum. Mol. Genet.,2010

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute kidney injury interacts with VKORC1 genotype on initiative warfarin dose among heart surgery recipients: a real-world research;Scientific Reports;2023-12-08

2. Efficacy of Warfarin Therapy Guided by Pharmacogenetics: A Real-world Investigation Among Han Taiwanese;Clinical Therapeutics;2023-07

3. Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies;Clinical Pharmacokinetics;2023-06

4. Acute kidney injury interacts with VKORC1 genotype on initiative warfarin dose among heart surgery recipients: a real-world research;2023-02-23

5. Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial;American Journal of Cardiovascular Drugs;2023-01